MB
Madhukar Bhagawan Pansare
About Madhukar Bhagawan Pansare
Data last updated:
Madhukar Bhagawan Pansare is a Designated Partner at Astrovia Lifesciences Llp (since 2025) and Partner at Asmarrk Therapeutics Llp (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astrovia Lifesciences Llp ACS-5923 | Designated Partner | 12 Nov 2025 | 2025 | Active | |
| Asmarrk Therapeutics Llp ACH-5562 | Partner | 04 Jun 2024 | 2024 | Active |
Board colleagues of Madhukar Bhagawan Pansare
| Name | DIN | Company | Designation |
|---|---|---|---|
| Priyanka Amol Pardeshi | 11378123 | Astrovia Lifesciences Llp | Designated Partner |
| Rohit Babanrao Mane | 07268354 | Astrovia Lifesciences Llp | Designated Partner |
| Shital Ketan Godse | 10655762 | Astrovia Lifesciences Llp , Asmarrk Therapeutics Llp | Designated Partner |
| Abhilash Aniruddharao More | 08066501 | Asmarrk Therapeutics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhukar Bhagawan Pansare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhukar Bhagawan Pansare
Madhukar Bhagawan Pansare currently holds 2 directorships: Astrovia Lifesciences Llp (Designated Partner, since 12 Nov 2025); Asmarrk Therapeutics Llp (Partner, since 04 Jun 2024).
Madhukar Bhagawan Pansare was first appointed on 04 Jun 2024 as Partner at Asmarrk Therapeutics Llp. The most recent appointment on record is 12 Nov 2025 at Astrovia Lifesciences Llp.
The current boards of Madhukar Bhagawan Pansare's companies include Priyanka Amol Pardeshi (Astrovia Lifesciences Llp), Rohit Babanrao Mane (Astrovia Lifesciences Llp), Shital Ketan Godse (Astrovia Lifesciences Llp), Abhilash Aniruddharao More (Asmarrk Therapeutics Llp).